P

Inventor

MARCHIONNI MARK

US20 patents
⚠️ This page may combine multiple inventors who share the name “MARCHIONNI MARK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ACORDA THERAPEUTICS INC

12 patents
US7037888B1May 2, 2006

Methods for treating muscle diseases and disorders

ACORDA THERAPEUTICS INC60 citations95
US7662772B2Feb 16, 2010

Methods for treating congestive heart failure

ACORDA THERAPEUTICS INC13 citations91
US7384756B1Jun 10, 2008

Methods for treating muscle diseases and disorders

ACORDA THERAPEUTICS INC14 citations91
US7115554B1Oct 3, 2006

Methods of increasing myotube formation or survival or muscle cell mitogenesis differentiation or survival using neuregulin GGF III

ACORDA THERAPEUTICS INC19 citations91
US7319019B1Jan 15, 2008

Glial mitogenic factors lacking an N-terminal signal sequence

ACORDA THERAPEUTICS INC18 citations90
US6890751B2May 10, 2005

NRG-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods

ACORDA THERAPEUTICS INC4 citations73
US8026213B2Sep 27, 2011

Methods for treating muscle diseases and disorders

ACORDA THERAPEUTICS INC3 citations72
US10232016B2Mar 19, 2019

Methods for treating congestive heart failure

ACORDA THERAPEUTICS INC1 citations71
US10065999B2Sep 4, 2018

Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by NRG-2

ACORDA THERAPEUTICS INC1 citations62
US7718606B2May 18, 2010

Methods for treating muscle diseases and disorders

ACORDA THERAPEUTICS INC1 citations61
US10717775B2Jul 21, 2020

Methods for cardiomyocyte survival, proliferation or differentiation by NRG-2

ACORDA THERAPEUTICS INC0 citations52
US7968678B2Jun 28, 2011

Glial mitogenic factors, their preparation and use

ACORDA THERAPEUTICS INC1 citations50

MARCHIONNI MARK

3 patents

CENES PHARMACEUTICALS INC

2 patents

CAMBRIDGE NEUROSCIENCE INC

2 patents

SCION PHARMACEUTICALS INC

1 patent